Clinical analytics firm Covera Health has announced the integration of Transpara from Dutch artificial intelligence (AI) developer ScreenPoint Medical into its quality analytics platform.
Transpara is ScreenPoint's AI-powered decision support software for 2D and 3D mammography that helps radiologists better identify cancer on mammography and reduce false-positive rates. The integration will allow Covera to bolster early breast cancer detection efforts and improve outcomes for women, the company noted.
Transpara is one of the first third-party applications that Covera has added to its platform. Covera intends to further improve its program by adding other third-party tools in the near future, the company said.